Mazdutide
Also known as: IBI362
Mazdutide is a dual GLP-1 / glucagon receptor agonist licensed from Eli Lilly to Innovent Biologics for Greater China. Approved by China's NMPA in June 2025 for chronic weight management and in September 2025 for glycemic control in type 2 diabetes; NOT FDA-approved in the US.
0 listings, ranked by trust score
Each row is a (vendor, peptide) pair. Click through for the listing detail, the vendor's full trust profile, and any COAs they've published.
No vendors carrying this peptide are indexed yet.
COAs for Mazdutide
6 third-party tests across 2 vendors. Each card links to the full report.
For
Mazdutide
by Profound Aminos· batch 2025-01-23
For
Mazdutide
by Profound Aminos· batch cmojb7xwe01f9kirx99syrvnd
For
Mazdutide
by Hydro Research Peptides· batch 2024-08-05
For
Mazdutide
by Hydro Research Peptides· batch Mazdutide-6015
Purity not on file
For
Mazdutide
by Hydro Research Peptides· batch Mazdutide-6015
Purity not on file
For
Mazdutide
by Hydro Research Peptides· batch Mazdutide-6015